Literature DB >> 10163628

Approaches to rationing drugs in hospitals. An Australian perspective.

F Bochner1, N G Burgess, E D Martin.   

Abstract

The increasing need to consider rationing strategies within the healthcare environment is being driven by pressures such as the development of new medical technologies, the aging population, patient awareness and expectations, healthcare professionals' appetite for new treatments, and government restrictions on healthcare costs. Solutions to these pressures will need to be sought urgently to avoid a situation in which quality of healthcare is affordable only for the wealthy. The fundamental principles of equity and fairness will need to be applied universally if the solutions are to be accepted by the community, patients and practitioners. There are several measures that a hospital must have in place before the concept of drug rationing can be contemplated. The approach essentially involves ensuring rational drug approval processes based on critical review of the available data, coupled with ongoing education and audit. Thus, accurate information and clinical budgeting systems, processes which encourage and ensure structural and technical efficiencies within the drug use sequence and an effective Drug and Therapeutics committee are required to facilitate this approach. To assist with its overriding goals of the quality use of medicines and optimal patient care, the Drug and Therapeutics committee needs to implement an effective formulary system, obtain detailed guidelines governing drug use within the institution, conduct an ongoing drug utilisation review programme, and provide education and training. The move to consider allocative decision making (rationing) will become increasingly necessary as limits on structural and technical efficiency measures are reached. An institution will then need to decide whether to treat a particular group of patients, or provide a certain form of treatment. Improved methods for community consultation need to be explored and there must be a partnership between the health provider and the consumer in enunciating the existence of scarcity, determining priorities and ensuring that ethics and equity are not abandoned through this process.

Entities:  

Mesh:

Year:  1996        PMID: 10163628     DOI: 10.2165/00019053-199610050-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  30 in total

1.  Conducting pharmacoeconomic evaluations in a hospital setting.

Authors:  L A Sanchez
Journal:  Hosp Pharm       Date:  1995-05

2.  Health care rationing.

Authors:  C Ham
Journal:  BMJ       Date:  1995-06-10

3.  Praxis makes perfect?

Authors:  J J Fins
Journal:  Hastings Cent Rep       Date:  1993 Sep-Oct       Impact factor: 2.683

4.  Hard times for hospital administrators. The problem of resource allocation.

Authors:  P Komesaroff
Journal:  Med J Aust       Date:  1994-04-18       Impact factor: 7.738

5.  Evaluating the cost containment potential of clinical guidelines.

Authors:  C E Carpenter; D B Nash; N E Johnson
Journal:  QRB Qual Rev Bull       Date:  1993-04

6.  The NSW health outcomes initiative and economic analysis.

Authors:  G Mooney; S Jan; J Seymour
Journal:  Aust J Public Health       Date:  1994-09

7.  Prioritising health services in an era of limits: the Oregon experience.

Authors:  J A Kitzhaber
Journal:  BMJ       Date:  1993-08-07

8.  Dimensions of rationing: who should do what?

Authors:  R Klein
Journal:  BMJ       Date:  1993-07-31

9.  Hospital drug therapy cost containment through a preferred medicines list and drug utilisation review system.

Authors:  M J Pearce; E J Begg
Journal:  N Z Med J       Date:  1994-03-23

10.  Clinical decision making: from theory to practice. Rationing resources while improving quality. How to get more for less.

Authors:  D M Eddy
Journal:  JAMA       Date:  1994-09-14       Impact factor: 56.272

View more
  5 in total

1.  Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitals.

Authors:  R Fijn; L T de Jong-van den Berg; J R Brouwers
Journal:  Pharm World Sci       Date:  1999-04

2.  Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.

Authors:  R Fijn; J R Brouwers; R J Knaap; L T De Jong-Van Den Berg
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

3.  Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery.

Authors:  John C Woodfield; Andre M Van Rij; Ross A Pettigrew; Antje van der Linden; Donna Bolt
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

4.  The validity of a questionnaire on medicines used in health care practice: comparison of a questionnaire and computerized medical record survey.

Authors:  Ahmad Al-Windi
Journal:  Eur J Clin Pharmacol       Date:  2003-07-04       Impact factor: 2.953

5.  Consumer involvement in Quality Use of Medicines (QUM) projects - lessons from Australia.

Authors:  Carl M J Kirkpatrick; Elizabeth E Roughead; Gregory R Monteith; Susan E Tett
Journal:  BMC Health Serv Res       Date:  2005-12-01       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.